NPCE IPOs 6.90M* shares @$17.00: https://www.globenewswire.com/news-release/2021/04/22/2214658/0/en/NeuroPace-Inc-Announces-Pricing-of-Initial-Public-Offering.html …NeuroPace is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. *Assuming exercise of underwriter’s option.